Virtu Financial’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $17K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $13K | Buy |
|
|||||
|
2022
Q3 | $12K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $87K | Sell |
|
|||||
|
2021
Q4 | $90K | Buy |
|
|||||
|
2021
Q3 | $88K | Sell |
|
|||||
|
2021
Q2 | $151K | Sell |
|
|||||
|
2021
Q1 | $318K | Buy |
|
|||||
|
2020
Q4 | $40K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $64K | Buy |
|
|||||
|
2018
Q4 | $7K | Sell |
|
|||||
|
2018
Q3 | $88K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $4K | Sell |
|
|||||
|
2017
Q4 | $152K | Buy |
|
|||||
|
2017
Q3 | $79K | Buy |
|